Visioneering Technologies Inc

AU:VTI Australia Medical Devices
Market Cap
$2.29 Million
AU$3.70 Million AUD
Market Cap Rank
#34921 Global
#1288 in Australia
Share Price
AU$0.07
Change (1 day)
+0.00%
52-Week Range
AU$0.07 - AU$0.07
All Time High
AU$55.00
About

Visioneering Technologies, Inc., a medical device company, engages in the design, manufacture, sale, and distribution of contact lenses in North America, Europe, and the Asia-Pacific. Its flagship product is NaturalVue, a multifocal 1-day contact lens for adults with presbyopia and children with myopia. The company was incorporated in 2008 and is headquartered in Alpharetta, Georgia.

Visioneering Technologies Inc - Asset Resilience Ratio

Latest as of June 2023: 26.73%

Visioneering Technologies Inc (VTI) has an Asset Resilience Ratio of 26.73% as of June 2023. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing.

Liquid Assets
AU$3.27 Million
Cash + Short-term Investments
Total Assets
AU$12.22 Million
All company assets
Resilience Assessment
Very High
Financial Resilience Level

Asset Resilience Ratio Trend (2016–2023)

This chart shows how Visioneering Technologies Inc's Asset Resilience Ratio has changed over time. Compare with other companies' asset resilience ratios.

Liquid Assets Composition Over Time

This chart breaks down Visioneering Technologies Inc's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time.

Current Liquid Assets Breakdown

Component Amount % of Total Assets
Cash & Equivalents AU$3.27 Million 26.73%
Short-term Investments AU$0.00 0%
Total Liquid Assets AU$3.27 Million 26.73%

Asset Resilience Insights

  • Very High Liquidity: Visioneering Technologies Inc maintains exceptional liquid asset reserves at 26.73% of total assets.
  • This level provides strong protection against economic uncertainties but may indicate potential for more aggressive growth investments.
  • The company primarily holds liquidity in cash and equivalents rather than short-term investments.

Visioneering Technologies Inc Industry Peers by Asset Resilience Ratio

Compare Visioneering Technologies Inc's asset resilience ratio with other companies in the same industry.

Company Industry Asset Resilience Ratio
Shanghai Kehua Bio-Engineering Co Ltd
SHE:002022
Medical Devices 0.01%
Jiangsu Yuyue Medical Equipment & Supply Co Ltd
SHE:002223
Medical Devices 0.26%
Double Medical Technology Inc
SHE:002901
Medical Devices 7.79%
Wuhan Easy Diagnosis Biomedicine Co Ltd Class A
SHE:002932
Medical Devices 6.64%
Shinhung
KO:004080
Medical Devices 4.17%
UMediC Group Berhad
KLSE:0256
Medical Devices 1.48%
Osang Healthcare Co.,Ltd
KQ:036220
Medical Devices 9.34%
HansBiomed Corporation
KQ:042520
Medical Devices 9.13%

Annual Asset Resilience Ratio for Visioneering Technologies Inc (2016–2023)

The table below shows the annual Asset Resilience Ratio data for Visioneering Technologies Inc.

Year Asset Resilience Ratio (%) Liquid Assets Total Assets Change
2023-12-31 12.46% AU$1.40 Million AU$11.21 Million -41.95pp
2022-12-31 54.41% AU$4.96 Million AU$9.11 Million -19.25pp
2021-12-31 73.66% AU$10.98 Million AU$14.91 Million +25.37pp
2020-12-31 48.29% AU$2.41 Million AU$4.99 Million +15.37pp
2019-12-31 32.92% AU$1.92 Million AU$5.83 Million -57.73pp
2018-12-31 90.64% AU$7.28 Million AU$8.03 Million +72.43pp
2016-12-31 18.22% AU$5.67 Million AU$31.14 Million --
pp = percentage points